Description

3-(Cyclopropylmethyl)-9-Oxa-3,7-Diazabicyclo[3.3.1]Nonane is a high-purity, advanced pharmaceutical intermediate featuring a unique bridged diazabicyclic structure. This compound matters as a critical building block in modern medicinal chemistry, enabling the synthesis of novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. It is primarily needed by research institutions and pharmaceutical companies engaged in the development of central nervous system (CNS) agents, receptor modulators, and other innovative small-molecule drugs.

Application

• Pharmaceutical Intermediate: A key synthon in the research and development of new drug candidates, particularly for neurological and psychiatric disorders.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Ligand Synthesis: Serves as a precursor for creating complex ligands targeting specific biological receptors and enzymes.
• Chemical Biology Probes: Employed in the development of molecular probes to study biological pathways and protein functions.
• Process Chemistry Development: Utilized in scaling up synthetic routes from laboratory to pilot plant and commercial manufacturing scales.
• Contract Research & Manufacturing (CRAM): Supplied to CROs and CDMOs supporting outsourced drug development projects for global clients.

Basic Information

Product Name	3-(Cyclopropylmethyl)-9-Oxa-3,7-Diazabicyclo[3.3.1]Nonane
CAS No.	1422059-05-9
Molecular Formula	C11H20N2O
Molecular Weight	196.29 g/mol
Synonyms	9-Oxa-3,7-diazabicyclo[3.3.1]nonane, 3-(cyclopropylmethyl)-; 3-(Cyclopropylmethyl)-9-oxa-3,7-diazabicyclo[3.3.1]nonane; 9-Oxa-3,7-diazabicyclo[3.3.1]nonane, 3-(cyclopropylmethyl)- (CAS 1422059-05-9); 3-Cyclopropylmethyl-9-oxa-3,7-diazabicyclo[3.3.1]nonane; Bridged diazabicyclic intermediate; CP-9-Oxa-3,7-DBN; Pharmaceutical intermediate 1422059-05-9
EINECS	Contact for details

Quality Control

Our 3-(Cyclopropylmethyl)-9-Oxa-3,7-Diazabicyclo[3.3.1]Nonane is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all critical quality attributes. Our production adheres to cGMP principles where applicable, supporting its use in regulated pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled under dry, inert conditions to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.